UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000016019
Receipt number R000018626
Scientific Title Effects of catheter position of continuous nerve block on the rehabilitation of total knee arthroplasty: femoral nerve block vs adductor canal block.
Date of disclosure of the study information 2015/01/01
Last modified on 2018/06/25 10:48:46

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of catheter position of continuous nerve block on the rehabilitation of total knee arthroplasty: femoral nerve block vs adductor canal block.

Acronym

Post TKA rehabilitation: FNB vs ACB

Scientific Title

Effects of catheter position of continuous nerve block on the rehabilitation of total knee arthroplasty: femoral nerve block vs adductor canal block.

Scientific Title:Acronym

Post TKA rehabilitation: FNB vs ACB

Region

Japan


Condition

Condition

knee osteoarthritis

Classification by specialty

Orthopedics Anesthesiology Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Continuous femoral nerve block (FNB) is popular analgesia for total knee arthroplasty (TKA), however it provides motor weakness of quadriceps muscle of thigh. One of principle problem on acute rehabilitation state is swelling and persisted motor weakness of thigh. Recently, continuous adductor canal block (ACB) is noted much less motor weakness of thigh than femoral nerve block. The aim of this study is to compare the thigh swelling and recovery of motor function of thigh on acute rehabilitation of TKA between FNB and ACB.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

maximum voluntary isometric constriction of quadriceps of thigh

Key secondary outcomes

girth of thigh
post operative pain
range of motion of knee
complication


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment Maneuver

Interventions/Control_1

continuous femoral nerve block for 72 hours postoperatively

Interventions/Control_2

continuous adductor canal block for 72 hours postoperatively

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >

Gender

Male and Female

Key inclusion criteria

Patients planning total knee arthroplasty

Key exclusion criteria

Patients with peripheral neuropathy, palsy, obese (BMI>35), anemia, anticoagulant therapy, renal failure, and heart failure

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Tatsuo Nakamoto

Organization

Osaka Rosai Hospital

Division name

Department of anesthesia and pain medicine

Zip code


Address

1179-3 Nagasone-cho, Kita-ku, Sakai, Osaka, JAPAN

TEL

072-252-3561

Email

tnakamoto@msic.med.osaka-cu.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Tatsuo Nakamoto

Organization

Osaka Rosai Hospital

Division name

Department of anesthesia and pain medicine

Zip code


Address

1179-3 Nagasone-cho, Kita-ku, Sakai, Osaka, JAPAN

TEL

072-252-3561

Homepage URL


Email

tnakamoto@msic.med.osaka-cu.ac.jp


Sponsor or person

Institute

Department of anesthesia and pain medicine, Osaka Rosai Hospital

Institute

Department

Personal name



Funding Source

Organization

self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

大阪労災病院(大阪府)


Other administrative information

Date of disclosure of the study information

2015 Year 01 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2014 Year 12 Month 19 Day

Date of IRB


Anticipated trial start date

2015 Year 01 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 12 Month 22 Day

Last modified on

2018 Year 06 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018626


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name